Key result
Anticoagulation therapy, including warfarin and factor Xa inhibitors, improves patient quality of life and reduces stroke risk in atrial fibrillation.
Why the study?
Do anticoagulants reduce stroke risk and improve quality of life in patients with atrial fibrillation?
Do anticoagulants reduce stroke risk and improve quality of life in patients with atrial fibrillation?
Anticoagulants, including warfarin and factor Xa inhibitors, are effective in reducing stroke risk and improving quality of life in patients with atrial fibrillation.
Supports anticoagulation in AF; leaves open need for updated meta-analyses of recent agents.
Atrial fibrillation can lead to the formation of emboli and increases the risk of stroke. As well as warfarin, a new class of anticoagulants, factor Xa inhibitors, are now available that work by inhibiting factor Xa, a factor needed to form blood clots. Anticoagulation therapy can improve patient quality of life and reduce stroke risk.
No takes yet. Share an insight, caveat, or question.
Linda Nazarko (2013) studied this question. Anticoagulation therapy, including warfarin and factor Xa inhibitors, improves patient quality of life and reduces stroke risk in atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: